Tamanho, âmbito, Condutores De Crescimento Do Mercado De Terapêutica Digital Prescrita (Pdtx) Da ásia-Pacífico

Asia Pacific Prescription Digital Therapeutics Dtx Market

Tamanho do mercado em biliões de dólares

CAGR : 24.20 %

Período de previsão	2022 –2029
Tamanho do mercado (ano base )	USD 96.38 Billion
Tamanho do mercado ( Ano de previsão)	USD 545.70 Billion
CAGR	24.20 %
Principais participantes do mercado	Manequim1 Manequim2 Manequim3 Manequim4 Manequim5 Pedido de desbloqueio

>Mercado de Terapêutica Digital de Prescrição Ásia-Pacífico (PDTx) , por mecanismo (mecanismos de entrada, mecanismos de saída), categoria ( aumento de medicamentos , substituição de medicamentos), tratamento (tratamento ambulatório, monoterapia), software (software para condições respiratórias , software para saúde mental , Software para perturbação por uso de opióides, software para diabetes, outros), serviços (microsserviços comportamentais, microsserviços médicos), acessibilidade de aplicações (Android, iOS, Windows), tipo de aplicação (aplicações nativas, aplicações da Web), aplicação (transtorno por uso de substâncias (SUD) , Transtorno por Uso de Opioides (OUD), Transtorno de Défice de Atenção/Hiperatividade (TDAH), Doença de Alzheimer, Transtorno Depressivo Major (TDM), Insónia, Epilepsia, Transtorno do Movimento, Esclerose Múltipla, Enxaqueca, Perturbação do Espectro do Autismo, Oncologia, Inflamação, Respiratório, Cardiovascular , Tratamento da Dor, Condições Metabólicas, Outros), Doentes (Crianças, Adultos) – Tendências e Previsões do Setor para 2029

Análise e dimensão do mercado

As terapias digitais prescritas são uma estratégia única que permite implementações de software para tratar rapidamente doenças graves. Foi concebido para fornecer tratamento baseado em evidências em qualquer lugar e a qualquer momento e para fornecer aos médicos dados em tempo real sobre o progresso do paciente. A terapêutica digital de prescrição foi desenvolvida e está em fase de desenvolvimento para uma variedade de doenças, incluindo perturbação por uso de substâncias (SUD), perturbação por uso de opióides (OUD), PHDA, perturbação depressiva major (TDM), insónia , esclerose múltipla, oncologia, enxaqueca , epilepsia, perturbação do espectro do autismo e doenças cardiovasculares. Os doentes com vários requisitos não cumpridos podem considerar as terapias digitais prescritas o aspeto mais crucial das suas vidas.

A Data Bridge Market Research analisa que o mercado de terapêutica digital de prescrição da Ásia-Pacífico (PDTx) foi avaliado em 96,38 milhões de dólares em 2021 e deverá atingir os 545,70 milhões de dólares até 2029, registando um CAGR de 24, 2% durante o período de previsão de 2022 a 2029 Para além dos insights de mercado, tais como o valor de mercado, a taxa de crescimento, os segmentos de mercado, a cobertura geográfica, os participantes do mercado e o cenário de mercado, o relatório de mercado com curadoria da equipa de a pesquisa de mercado da Data Bridge também inclui análises especializadas aprofundadas, epidemiologia do paciente, análise de pipeline, análise de preços e estrutura regulamentar.

Âmbito do relatório e segmentação de mercado

Métrica de relatório	Detalhes
Período de previsão	2022 a 2029
Ano base	2021
Anos históricos	2020 (personalizável para 2014 - 2019)
Unidades Quantitativas	Receita em milhões de dólares, volumes em unidades, preços em dólares
Segmentos cobertos	Mecanismo (mecanismos de entrada, mecanismos de saída), categoria (aumento de medicação, substituição de medicação), tratamento (tratamento ambulatório, monoterapia), software (software para condições respiratórias, software para saúde mental, software para perturbação por uso de opióides, software para diabetes, outros) , Serviços (microsserviços comportamentais, microsserviços médicos), acessibilidade de aplicações (Android, iOS, Windows), tipo de aplicação (aplicações nativas, aplicações Web), aplicações (transtorno por uso de substâncias (SUD), perturbação por uso de opióides (OUD), défice de atenção/hiperatividade Perturbação (PHDA), doença de Alzheimer, perturbação depressiva major (TDM), insónia, epilepsia, perturbação do movimento, esclerose múltipla, enxaqueca, perturbação do espectro do autismo, oncologia , inflamação, respiratório, cardiovascular, controlo da dor, condições metabólicas, outros), doentes ( Crianças, Adultos),
Países abrangidos	China, Japão, Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC)
Participantes do mercado abrangidos	ResMed (EUA), SAMSUNGHEALTHCARE (Coreia do Sul), Biofourmis (EUA), Novartis AG (Suíça), Medtronic (Irlanda), Pear Therapeutics, Inc.
Oportunidades de mercado	Aumento do número de atividades de investigação e desenvolvimento Forte pipeline de potenciais produtos

Definição de mercado

As terapias digitais prescritas são um tipo de software utilizado para tratar uma variedade de doenças. Os medicamentos digitais prescritos foram criados combinando biologia e tecnologia. A inteligência artificial, diversos algoritmos e realidade virtual são utilizados para criar estes instrumentos terapêuticos. Os doentes podem utilizar software e serviços terapêuticos digitais prescritos para obter qualquer forma de tratamento quando e onde necessitam. Os tratamentos digitais sujeitos a receita médica ganharam muita popularidade, uma vez que são rigorosamente regulamentados pela FDA e outras autoridades reguladoras e só podem ser utilizados com uma prescrição médica adequada.

Dinâmica do mercado da terapêutica digital de prescrição da Ásia-Pacífico (PDTx)

Motoristas

Aumento da prevalência de doenças crónicas

A crescente prevalência de doenças crónicas é um fator importante que impulsiona a taxa de crescimento do mercado de terapêutica digital de prescrição (PDTx) durante o período de previsão de 2022-2029. De acordo com a Organização Mundial de Saúde (OMS), 463 milhões de adultos teriam diabetes em 2020. Segundo as previsões, existiriam cerca de 629 milhões de diabéticos em todo o mundo até 2045.

Aumentar o investimento em infraestruturas de saúde

Outro fator significativo que influencia a taxa de crescimento do mercado da terapêutica digital de prescrição (PDTx) é o aumento dos gastos com a saúde que ajuda a melhorar a sua infraestrutura. Além disso, várias organizações governamentais pretendem melhorar a infra-estrutura de saúde aumentando o financiamento e isto influenciará ainda mais a dinâmica do mercado.

Além disso, a crescente taxa de adoção de smartphones e tablets irá expandir o mercado da terapêutica digital de prescrição (PDTx). Além disso, o aumento das iniciativas governamentais para melhores serviços de saúde e o aumento da população geriátrica resultarão na expansão do mercado da terapêutica digital de prescrição (PDTx). A par disto, a fácil acessibilidade, o conforto do paciente e a potencialidade de influenciar a mudança comportamental aumentarão a taxa de crescimento do mercado.

Oportunidades

Forte pipeline de potenciais produtos

Um pipeline significativo de potenciais artigos concebidos para serem lançados ao longo do período de previsão proporcionará oportunidades benéficas para o crescimento do mercado de terapêutica digital de prescrição (PDTx). Pear-011 (ansiedade GAD), Pear-015 (depressão MDD), que são utilizados no tratamento de adultos com insónia crónica e depressão, e CT-152 (perturbação depressiva major), CT-155 (esquizofrenia), que são utilizados no tratamento de adultos com esquizofrenia e depressão, são ilustrações de potenciais produtos terapêuticos clínicos da pera na fase III. Como resultado, prevê-se que vários medicamentos em fase avançada em preparação ofereçam perspetivas atraentes para o florescimento do mercado terapêutico digital.

O crescimento do mercado é alimentado por um aumento do número de atividades de investigação e desenvolvimento. Isto proporcionará oportunidades benéficas para o crescimento do mercado dos produtos biológicos. Além disso, o aumento do investimento para o desenvolvimento de tecnologias avançadas e o aumento do número de mercados emergentes proporcionarão ainda mais oportunidades benéficas para o crescimento da terapêutica digital de prescrição (PDTx) durante o período de previsão.

Restrições/Desafios

Por outro lado, as preocupações com a privacidade dos dados dos doentes obstruirão a taxa de crescimento do mercado. A falta de infraestruturas de saúde nas economias em desenvolvimento e a escassez de profissionais qualificados desafiarão o mercado da terapêutica digital de prescrição (PDTx). Além disso, as regulamentações governamentais rigorosas e a falta de sensibilização para a terapêutica digital nos países em desenvolvimento funcionarão como restrições e impedirão ainda mais a taxa de crescimento do mercado durante o período de previsão de 2022-2029.

Este relatório de mercado de terapêutica digital de prescrição da Ásia-Pacífico (PDTx) fornece detalhes de novos desenvolvimentos recentes, regulamentos comerciais, análise de importação-exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, análise estratégica do crescimento do mercado, tamanho do mercado, crescimento do mercado da categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado. Para mais informações sobre o mercado de terapêutica digital de prescrição (PDTx) da Ásia-Pacífico, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado.

Patient Epidemiology Analysis

Prescription digital therapeutics (PDTx) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Asia-Pacific Prescription Digital Therapeutics (PDTx) Market

COVID-19 has a positive general influence on the prescription digital therapeutics (PDTx) sector. Due to increased global awareness of the relevance of digital health, the prevalence of mental illness, and the rate of drug usage. Furthermore, because individuals were forced to stay at home during the pandemic, less physical exercise, an unhealthy lifestyle, and mental stress increased the prevalence of chronic diseases. As a result, demand for prescription digital therapeutics (PDTx) devices and software is increasing around the world. The industry is expected to increase further since regulatory clearances for prescription digital therapeutics (PDTx)-based treatments have recently been eased.

In the middle of the COVID-19 outbreak, the US FDA issued provisional advice for Pear Therapeutics' mental health medications. It also implies that regulatory agencies recognize the significance of digital therapeutics goods. In addition, digital health businesses in the United States raised USD 5.4 billion in venture capital in the first half of 2020, a record high in the history of digital health funding, indicating that investors believe these solutions are necessary. Hence, the COVID-19 pandemic is predicted to boost the market for prescription digital therapeutics (PDTx).

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Scope

The Asia-Pacific prescription digital therapeutics (PDTx) market is segmented on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Mechanism

Input Mechanisms
Output Mechanisms

Category

Medication Augmentation
Medication Replacement

Treatment

Outpatient Treatment
Monotherapy

Software

Software for Respiratory Conditions
Software for Mental Health
Software for Opioid Use Disorder
Software for Diabetes
Others

Services

Behavioral Microservices
Medical Microservices

App Accessibility

Android
iOS
Windows

App Type

Native Apps
Web Apps

Application

Substance Use Disorder (SUD)
Opioid Use Disorder (OUD)
Attention Deficit/Hyperactivity Disorder (ADHD)
Alzheimer’s Disease
Major Depressive Disorder (MDD)
Insomnia
Epilepsy
Movement Disorder
Multiple Sclerosis
Migraine
Autism Spectrum Disorder
Oncology
Inflammation
Respiratory
Cardiovascular
Pain Management
Metabolic Conditions
Others

Patients

Children
Adults

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Regional Analysis/Insights

The Asia-Pacific prescription digital therapeutics (PDTx) market is analysed and market size insights and trends are provided by country, mechanism, category, treatment, software, services, app accessibility, app type, application and patients as referenced above.

The countries covered in the Asia-Pacific prescription digital therapeutics (PDTx) market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

Japan dominates the Asia-Pacific prescription digital therapeutics (PDTx) market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising healthcare expenditure and increasing prevalence of chronic diseases will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Share Analysis

The Asia-Pacific prescription digital therapeutics (PDTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific prescription digital therapeutics (PDTx) market.

Some of the major players operating in the Asia-Pacific prescription digital therapeutics (PDTx) market are:

ResMed (US)
SAMSUNGHEALTHCARE (South Korea)
Biofourmis (US)
Novartis AG (Switzerland)
Medtronic (Ireland)
Pear Therapeutics, Inc. (US)
Voluntis (France)

SKU-58518

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Click on image to enlarge

Painel interativo de análise de dados
Painel de análise da empresa para oportunidades de elevado potencial de crescimento
Acesso de analista de pesquisa para personalização e customização. consultas
Análise da concorrência com painel interativo
Últimas notícias, atualizações e atualizações Análise de tendências
Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência

Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 MECHANISM OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INESIGHT

4.1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: LAWS AND REGULATIONS

4.2 PRINCIPLES FOR THE DEVELOPMENT OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) GUIDELINES

4.3 HIPAA COMPLIANCE FOR PRESCRIPTION DIGITAL THERAPEUTICS (PDTX)

5 EPIDERMOLOGY

6 PIPELINE ANALYSIS

6.1 LIST OF PIPELINE PRODUCTS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 PRESENCE OF PRODUCT PIPELINE

7.1.2 INCREASING PREVALANCE OF DISEASES

7.1.3 HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS

7.1.4 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES

7.1.5 PRESENCE OF REIMBURSEMENT

7.2 RESTRAINTS

7.2.1 UNAFFORDABILITY OF DIGITAL THERAPEUTICS

7.2.2 PRIVACY ISSUES IN PRESCRIPTION DIGITAL HEALTHCARE

7.2.3 RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDERS

7.3 OPPORTUNITIES

7.3.1 INCREASING FUNDING ACTIVITIES

7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

7.3.3 EXPLORATION OF EMERGING MARKET

7.3.4 INCREASING HEALTHCARE EXPENDITURE

7.4 CHALLENGES

7.4.1 LACK OF SKILLED RESOURCES

7.4.2 EXISTENCE OF TRADITIONAL MEDICATIONS

7.4.3 LONG APPROVAL PROCEDURE

8 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

8.1 PRICE IMPACT

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC DECISIONS FOR MANUFACTURERS

8.5 CONCLUSION

9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM

9.1 OVERVIEW

9.2 INPUT MECHANISMS

9.2.1 PATIENT DATA COLLECTION

9.2.1.1 Cognition

9.2.1.2 Mood

9.2.1.3 Memory

9.2.1.4 Concentration

9.2.1.5 Familial Recognition

9.2.1.6 Others

9.2.2 DEXTERITY OR STEADINESS MEASUREMENT

9.2.2.1 Range of Motion Tests

9.2.2.2 Stretching

9.2.2.3 Others

9.2.3 AUDIO ANALYSIS

9.2.3.1 Shakiness

9.2.3.2 Voice Quality

9.2.3.3 Others

9.2.3.4 Screen

9.2.3.5 Accelerometer

9.2.3.6 Microphone

9.3 OUTPUT MECHANISMS

9.3.1 PATIENT COMMUNICATION

9.3.1.1 Professional Coaching

9.3.1.2 Peer-to-Peer Support

9.3.1.3 Others

9.3.2 ADHERENCE PROMPTS

9.3.2.1 Sleep

9.3.2.2 Diet

9.3.2.3 Inactivity

9.3.2.4 Others

9.3.3 CONTENT DELIVERY

9.3.3.1 Blogs

9.3.3.2 Tips

9.3.3.3 Videos

9.3.3.4 FAQs

9.3.3.5 Others

9.3.3.6 Chat

9.3.3.7 Notification

10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY

10.1 OVERVIEW

10.2 MEDICATION AUGMENTATION

10.3 MEDICATION REPLACEMENT

11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT

11.1 OVERVIEW

11.2 OUTPATIENT TREATMENT

11.2.1 COGNITIVE BEHAVIOR THERAPY (CBT)

11.2.2 CONTINGENCY MANAGEMENT

11.2.3 CRAVING OR TRIGGER ASSESSMENT

11.2.4 FLUENCY TRAINING

11.2.5 TRANSMUCOSAL BUPRENORPHINE

11.2.6 OTHERS

11.3 MONOTHERAPY

11.3.1 COGNITIVE RESTRUCTURING

11.3.2 INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBT)

11.3.3 OTHERS

12 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE

12.1 OVERVIEW

12.2 4.2 SOFTWARE FOR DIABETES

12.3 SOFTWARE FOR MENTAL HEALTH

12.4 SOFTWARE FOR RESPIRATORY CONDITIONS

12.5 SOFTWARE FOR OPIOID USE DISORDER

12.6 OTHERS

13 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES

13.1 OVERVIEW

13.2 BEHAVIORAL MICROSERVICES

13.2.1 PHYSICAL ACTIVITY

13.2.2 TELEMEDICINE

13.2.3 CONTROLLED BREATHING

13.2.4 MINDFULNESS TRAINING

13.2.5 RELAXATION TECHNIQUE

13.2.6 DIET OPTIMIZATION

13.2.7 OTHERS

13.3 MEDICAL MICROSERVICES

13.3.1 MEDICATION MANAGEMENT SYSTEM

13.3.2 PATIENT HEALTH QUESTIONNAIRE

13.3.3 HEALTH RECOVERED ENGINE

13.3.4 FAGERSTRÖM TEST

13.3.5 MORISKY MEDICATION ADHERENCE SCALE

13.3.6 FINANCIAL SAVING ENGINE

13.3.7 OTHERS

14 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY

14.1 OVERVIEW

14.2 ANDROID

14.2.1 SMARTPHONE

14.2.2 TABLET

14.3 OS

14.3.1 SMARTPHONE

14.3.2 TABLET

14.4 WINDOWS

14.4.1 SMARTPHONE

14.4.2 TABLET

15 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE

15.1 OVERVIEW

15.2 NATIVE APPS

15.3 WEB APPS

16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION

16.1 OVERVIEW

16.2 METABOLIC CONDITIONS

16.3 MAJOR DEPRESSIVE DIORDER (MDD)

16.4 RESPIRATORY

16.5 CARDIOVASCULAR

16.6 SUBSTANCE USE DISORDER (SUD)

16.7 OPIOID USE DISORDERS (OUD)

16.8 INSOMNIA

16.9 PAIN MANAGEMENT

16.1 ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

16.11 MOVEMENT DISORDER

16.12 INFLAMMATION

16.13 ONCOLOGY

16.14 MIGRAINE

16.15 ALZHEIMER’S DISEASE

16.16 EPILEPSY

16.17 MULTIPLE SCLEROSIS

16.18 AUSTISM SPECTRUM DISORDER

16.19 OTHERS

17 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS

17.1 OVERVIEW

17.2 ADULTS

17.3 CHILDREN

18 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY GEOGRAPHY

18.1 ASIA -PACIFIC

18.1.1 JAPAN

18.1.2 CHINA

18.1.3 AUSTRALIA

18.1.4 SOUTH KOREA

18.1.5 INDIA

18.1.6 SINGAPORE

18.1.7 THAILAND

18.1.8 MALAYSIA

18.1.9 INDONESIA

18.1.10 PHILIPPINES

18.1.11 VIETNAM

18.1.12 REST OF ASIA- PACIFIC

19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY LANDSCAPE

19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

20 SWOT ANALYSIS

21 COMPANY PROFILE

21.1 OMADA HEALTH, INC.

21.1.1 COMPANY SNAPSHOT

21.1.2 PRODUCT PORTFOLIO

21.1.3 RECENT DEVELOPMENTS

21.2 RESMED

21.2.1 COMPANY SNAPSHOT

21.2.2 REVENUE ANALYSIS

21.2.3 COMPANY SHARE ANALYSIS

21.2.4 PRODUCT PORTFOLIO

21.2.5 RECENT DEVELOPMENTS

21.3 SAMSUNG

21.3.1 COMPANY SNAPSHOT

21.3.2 REVENUE ANALYSIS

21.3.3 COMPANY SHARE ANALYSIS

21.3.4 PRODUCT PORTFOLIO

21.3.5 RECENT DEVELOPMENT

21.4 GAIA AG

21.4.1 COMPANY SNAPSHOT

21.4.2 COMPANY SHARE ANALYSIS

21.4.3 PRODUCT PORTFOLIO

21.4.4 RECENT DEVELOPMENTS

21.5 PEAR THERAPEUTICS, INC.

21.5.1 COMPANY SNAPSHOT

21.5.2 COMPANY SHARE ANALYSIS

21.5.3 PRODUCT PORTFOLIO

21.5.4 RECENT DEVELOPMENTS

21.6 WELLDOC’S BLUESTAR

21.6.1 COMPANY SNAPSHOT

21.6.2 PRODUCT PORTFOLIO

21.6.3 RECENT DEVELOPMENTS

21.7 SOLERA NETWORK

21.7.1 COMPANY SNAPSHOT

21.7.2 PRODUCT PORTFOLIO

21.7.3 RECENT DEVELOPMENTS

21.8 AKILI INTERACTIVE LABS, INC.

21.8.1 COMPANY SNAPSHOT

21.8.2 PRODUCT PORTFOLIO

21.8.3 RECENT DEVELOPMENTS

21.9 BETTER THERAPEUTICS, LLC

21.9.1 COMPANY SNAPSHOT

21.9.2 PIPELINE PRODUCT PORTFOLIO

21.9.3 RECENT DEVELOPMENTS

21.1 BIGHEALTH

21.10.1 COMPANY SNAPSHOT

21.10.2 SOLUTION PORTFOLIO

21.10.3 RECENT DEVELOPMENT

21.11 BIOFOURMIS

21.11.1 COMPANY SNAPSHOT

21.11.2 PRODUCT PORTFOLIO

21.11.3 RECENT DEVELOPMENTS

21.12 CLICK THERAPEUTICS, INC.

21.12.1 COMPANY SNAPSHOT

21.12.2 PRODUCT PORTFOLIO

21.12.3 RECENT DEVELOPMENTS

21.13 HAPPIFY, INC.

21.13.1 COMPANY SNAPSHOT

21.13.2 PRODUCT PORTFOLIO

21.13.3 RECENT DEVELOPMENTS

21.14 LIMBIX HEALTH, INC.

21.14.1 COMPANY SNAPSHOT

21.14.2 PRODUCT PORTFOLIO

21.14.3 RECENT DEVELOPMENTS

21.15 NATURALCYCLES NORDIC AB

21.15.1 COMPANY SNAPSHOT

21.15.2 PRODUCT PORTFOLIO

21.15.3 RECENT DEVELOPMENTS

21.16 NUVOAIR AB

21.16.1 COMPANY SNAPSHOT

21.16.2 PRODUCT PORTFOLIO

21.16.3 RECENT DEVELOPMENTS

21.17 SENSYNE HEALTH PLC

21.17.1 COMPANY SNAPSHOT

21.17.2 REVENUE ANALYSIS

21.17.3 PRODUCT PORTFOLIO

21.17.4 RECENT DEVELOPMENTS

21.18 VOLUNTIS

21.18.1 COMPANY SNAPSHOT

21.18.2 REVENUE ANALYSIS

21.18.3 PRODUCT PORTFOLIO

21.18.4 RECENT DEVELOPMENTS

21.19 XEALTH

21.19.1 COMPANY SNAPSHOT

21.19.2 PRODUCT PORTFOLIO

21.19.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

Lista de Tabela

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS

TABLE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)

TABLE 4 ASIA-PACIFIC INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 5 ASIA-PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 6 ASIA-PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 7 ASIA-PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 8 ASIA-PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 9 ASIA-PACIFICINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 10 ASIA-PACIFIC OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 11 ASIA-PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 13 ASIA-PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 14 ASIA-PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 15 ASIA-PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)

TABLE 17 ASIA-PACIFIC MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 18 ASIA-PACIFIC MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 22 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 23 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)

TABLE 31 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 32 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 33 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 34 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 40 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 41 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)

TABLE 43 ASIA-PACIFIC NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 44 ASIA-PACIFIC WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 47 ASIA-PACIFIC MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 48 ASIA-PACIFIC RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 49 ASIA-PACIFIC CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 50 ASIA-PACIFIC SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 51 ASIA-PACIFIC OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 52 ASIA-PACIFIC INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 53 ASIA-PACIFIC PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 54 ASIA-PACIFIC ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 55 ASIA-PACIFIC MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 56 ASIA-PACIFIC INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 57 ASIA-PACIFIC ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 58 ASIA-PACIFIC MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 59 ASIA-PACIFIC ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 60 ASIA-PACIFIC EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 61 ASIA-PACIFIC MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 62 ASIA-PACIFIC AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 63 ASIA-PACIFIC OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 64 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)

TABLE 65 ASIA-PACIFIC ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 66 ASIA-PACIFIC CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 67 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 68 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 69 ASIA- PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 70 ASIA- PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 71 ASIA- PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 72 ASIA- PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 73 ASIA- PACIFIC INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 74 ASIA- PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 75 ASIA- PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 76 ASIA- PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 77 ASIA- PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 78 ASIA- PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 79 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 80 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 81 ASIA- PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 82 ASIA- PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 83 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 84 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 85 ASIA- PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 86 ASIA- PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 87 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 88 ASIA- PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 89 ASIA- PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 90 ASIA- PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 91 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 92 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 93 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 94 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 95 JAPAN INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 96 JAPAN PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 97 JAPAN DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 98 JAPAN AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 99 JAPAN INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 100 JAPAN OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 101 JAPAN PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 102 JAPAN ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 103 JAPAN CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 104 JAPAN OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 105 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 106 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 107 JAPAN OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 108 JAPAN MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 109 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 110 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 111 JAPAN BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 112 JAPAN MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 113 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 114 JAPAN ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 115 JAPAN IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 116 JAPAN WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 117 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 118 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 119 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 120 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 121 CHINA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 122 CHINA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 123 CHINA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 124 CHINA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 125 CHINA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 126 CHINA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 127 CHINA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 128 CHINA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 129 CHINA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 130 CHINA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 131 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 132 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 133 CHINA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 134 CHINA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 135 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 136 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 137 CHINA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 138 CHINA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 139 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 140 CHINA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 141 CHINA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 142 CHINA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 143 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 144 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 145 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 146 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 147 AUSTRALIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 148 AUSTRALIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 149 AUSTRALIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 150 AUSTRALIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 151 AUSTRALIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 152 AUSTRALIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 153 AUSTRALIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 154 AUSTRALIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 155 USTRALIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 156 AUSTRALIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 157 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 158 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 159 AUSTRALIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 160 AUSTRALIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 161 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 162 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 163 AUSTRALIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 164 AUSTRALIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 165 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 166 AUSTRALIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 167 AUSTRALIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 168 AUSTRALIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 169 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 170

TABLE 171 USTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 172 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 173 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 174 SOUTH KOREA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 175 SOUTH KOREA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 176 SOUTH KOREA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 177 SOUTH KOREA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 178 SOUTH KOREA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 179 SOUTH KOREA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 180 SOUTH KOREA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 181 SOUTH KOREA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 182 SOUTH KOREA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 183 SOUTH KOREA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 184 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 185 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 186 SOUTH KOREA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 187 SOUTH KOREA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 188 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 189 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 190 SOUTH KOREA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 191 SOUTH KOREA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 192 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 193 SOUTH KOREA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 194 SOUTH KOREA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 195 SOUTH KOREA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 196 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 197 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 198 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 199 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 200 INDIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 201 INDIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 202 INDIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 203 INDIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 204 INDIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 205 INDIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 206 INDIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 207 INDIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 208 INDIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 209 INDIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 210 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 211 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 212 INDIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 213 INDIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 214 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 215 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 216 INDIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 217 INDIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 218 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 219 INDIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 220 INDIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 221 INDIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 222 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 223 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 224 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 225 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 226 SINGAPORE INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 227 SINGAPORE PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 228 SINGAPORE DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 229 SINGAPORE AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 230 SINGAPORE INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 231 INGAPORE OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 232 SINGAPORE PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 233 SINGAPORE ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 234 SINGAPORE CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 235 SINGAPORE OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 236 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 237 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 238 SINGAPORE OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 239 SINGAPORE MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 240 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 241 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 242 SINGAPORE BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 243 SINGAPORE MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 244 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 245 SINGAPORE ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 246 SINGAPORE IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 247 SINGAPORE WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 248 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 249 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 250 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 251 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 252 THAILAND INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 253 THAILAND PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 254 THAILAND DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 255 THAILAND AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 256 THAILAND INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 257 THAILAND OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 258 THAILAND PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 259 THAILAND ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 260 THAILAND CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 261 THAILAND OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 262 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 263 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 264 THAILAND OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 265 THAILAND MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 266 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 267 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 268 THAILAND BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 269 THAILAND MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 270 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 271 THAILAND ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 272 THAILAND IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 273 THAILAND WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 274 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 275 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 276 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 277 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 278 MALAYSIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 279 MALAYSIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 280 MALAYSIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 281 MALAYSIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 282 MALAYSIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 283 MALAYSIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 284 MALAYSIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 285 MALAYSIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 286 MALAYSIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 287 MALAYSIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 288 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 289 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 290 MALAYSIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 291 MALAYSIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 292 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 293 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 294 MALAYSIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 295 MALAYSIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 296 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 297 MALAYSIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 298 MALAYSIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 299 MALAYSIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 300 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 301 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 302 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 303 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 304 INDONESIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 305 INDONESIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 306 INDONESIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 307 INDONESIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 308 INDONESIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 309 INDONESIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 310 INDONESIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 311 INDONESIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 312 INDONESIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 313 INDONESIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 314 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 315 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 316 INDONESIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 317 INDONESIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 318 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 319 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 320 INDONESIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 321 INDONESIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 322 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 323 INDONESIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 324 INDONESIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 325 INDONESIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 326 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 327 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 328 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 329 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 330 PHILIPPINES INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 331 PHILIPPINES PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 332 PHILIPPINES DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 333 PHILIPPINES AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 334 PHILIPPINES INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 335 HILIPPINES OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 336 PHILIPPINES PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 337 PHILIPPINES ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 338 PHILIPPINES CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 339 PHILIPPINES OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 340 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 341 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 342 PHILIPPINES OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 343 PHILIPPINES MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 344 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 345 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 346 PHILIPPINES BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 347 PHILIPPINES MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 348 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 349 PHILIPPINES ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 350 PHILIPPINES IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 351 PHILIPPINES WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 352 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 353 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 354 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 355 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 356 VIETNAM INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 357 VIETNAM PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 358 VIETNAM DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 359 VIETNAM AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 360 VIETNAM INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 361 VIETNAM OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 362 VIETNAM PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 363 VIETNAM ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 364 VIETNAM CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 365 VIETNAM OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 366 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 367 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 368 VIETNAM OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 369 VIETNAM MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 370 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 371 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 372 VIETNAM BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 373 VIETNAM MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 374 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 375 VIETNAM ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 376 VIETNAM IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 377 VIETNAM WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 378 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 379 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 380 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 381 REST OF ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

Lista de Figura

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 12 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES AND HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS IS DRIVING THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 13 INPUT MECHANISMS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN 2020 & 2027

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

FIGURE 15 DEATH CAUSE IN EUROPEAN UNION IN 2016

FIGURE 16 OCCURRENCE OF MIGRAINE AS PER THE AUSTRALIAN AND NEW ZEALAND ASSOCIATION OF NEUROLOGISTS ANNUAL SCIENTIFIC MEETING 2017

FIGURE 17 PROJECTED NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (IN MILLIONS)

FIGURE 18 PERCENTAGE OF INTERNET USERS IN 2016 AND 2019

FIGURE 19 HEALTHCARE EXPENDITURE IN 2016 AND 2019

FIGURE 20 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019

FIGURE 21 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019-2027 (USD MILLION)

FIGURE 22 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, CAGR (2020-2027)

FIGURE 23 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019

FIGURE 25 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019-2027 (USD MILLION)

FIGURE 26 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, CAGR (2020-2027)

FIGURE 27 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019

FIGURE 29 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)

FIGURE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, CAGR (2020-2027)

FIGURE 31 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019

FIGURE 33 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019-2027 (USD MILLION)

FIGURE 34 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, CAGR (2020-2027)

FIGURE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019

FIGURE 37 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019-2027 (USD MILLION)

FIGURE 38 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, CAGR (2020-2027)

FIGURE 39 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, LIFELINE CURVE

FIGURE 40 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019

FIGURE 41 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019-2027 (USD MILLION)

FIGURE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, CAGR (2020-2027)

FIGURE 43 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, LIFELINE CURVE

FIGURE 44 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019

FIGURE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019-2027 (USD MILLION)

FIGURE 46 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, CAGR (2020-2027)

FIGURE 47 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, LIFELINE CURVE

FIGURE 48 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019

FIGURE 49 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)

FIGURE 50 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, CAGR (2020-2027)

FIGURE 51 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 52 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019

FIGURE 53 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019-2027 (USD MILLION)

FIGURE 54 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, CAGR (2020-2027)

FIGURE 55 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, LIFELINE CURVE

FIGURE 56 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SNAPSHOT (2019)

FIGURE 57 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019)

FIGURE 58 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2020 & 2027)

FIGURE 59 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019 & 2027)

FIGURE 60 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM (2020-2027)

FIGURE 61 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY SHARE 2019 (%)

View Detailed Information

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

What is the future value of the Market?

The market value for Asia-Pacific Prescription Digital Therapeutics (PDTx) Market is expected USD 545.70 million by 2029.

What is the growth rate of the Market?

The Prescription Digital Therapeutics (PDTx) Market is to grow at a CAGR of 24.2% during the forecast period of 2022 to 2029

What is the application segment?

On the basis of application, the Asia-Pacific Prescription Digital Therapeutics (PDTx) Marketis segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others.

Who are the major players operating in the market?

The major players operating in the Asia-Pacific Prescription Digital Therapeutics (PDTx) Market are ResMed (US), SAMSUNGHEALTHCARE (South Korea), Biofourmis (US), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (US), Voluntis (France).

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2029

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2029

Asia Pacific Prescription Digital Therapeutics Dtx Market

CAGR : 24.20 %

Dinâmica do mercado da terapêutica digital de prescrição da Ásia-Pacífico (PDTx)

COVID-19 Impact on Asia-Pacific Prescription Digital Therapeutics (PDTx) Market

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Scope

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Regional Analysis/Insights

Competitive Landscape and Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Share Analysis

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Índice

Lista de Tabela

Lista de Figura

Metodologia de Investigação

Personalização disponível

Perguntas frequentes

Relatórios

Informações de mercado

Apoiar

Soluções

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2029

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2029

Asia Pacific Prescription Digital Therapeutics Dtx Market

CAGR : 24.20 %

Dinâmica do mercado da terapêutica digital de prescrição da Ásia-Pacífico (PDTx)

COVID-19 Impact on Asia-Pacific Prescription Digital Therapeutics (PDTx) Market

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Scope

Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Regional Analysis/Insights

Competitive Landscape and Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Share Analysis

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Índice

Lista de Tabela

Lista de Figura

Metodologia de Investigação

Personalização disponível

Perguntas frequentes

Navegue pelas páginas relacionadas